Nov. 6, 2025 — Lunit, a provider of AI for cancer diagnostics and precision oncology, recently announced that Volpara Health Technologies will now operate under the Lunit brand, introducing a unified global identity that merges their complementary strengths in breast health and AI innovation. This builds on Lunit’s 2024 acquisition of Volpara, an important step that aligned both companies under one vision: to conquer cancer through AI.

The Expansion of Teleradiology

Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology department workflows.

“All radiologists are teleradiologists now,” says Morris Panner, president of Intelerad Medical Systems, a Montreal-based provider of medical imaging software platforms. “The notion that you will not use cloud or distributed technology to enable your practice and your ability to care for people — those days are gone.”

Nov. 4, 2025 — Altamont Software, a provider of enterprise medical connectivity solutions, has announced the availability of its Dynamic Content engine within Passport SR. This feature provides the ability to calculate numerical values or generate text from data received from modalities and insert it into a report template.

Oct. 28, 2025 — Using targeted radiation during surgery — referred to as intraoperative radiation — to eliminate pancreatic cancer cells that have spread to areas around the pancreas, investigators at Johns Hopkins have been able to reduce the recurrence rate around the pancreas to 5%. This is believed to be the lowest ever reported for this population of patients, according to a preliminary study by the team from the Johns Hopkins Kimmel Cancer Center.

Nov. 3, 2025 — QT Imaging Holdings has announced that its chief medical officer, Elaine luanow, MD, will host a seminar titled “Quantitative Transmission Imaging Technology: The Future of Breast Imaging with Safe Volumetric Ultrasound” at the upcoming annual meeting of the Radiological Society of North America (RSNA 2025)  in Chicago, IL, Nov. 30 to Dec. 4, 2025.

Nov. 3, 2025 — —A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. The regimen, which pre-treats the tumor before delivering targeted alpha-radioimmunotherapy, resulted in durable major responses — including histologic cures — with minimal toxicities, paving the way for a safer and more effective treatment option for breast cancer patients.

Oct. 31, 2025 — Echolight plans to demonstrate its bone density scanning technology at the Radiological Society of North America (RSNA) 2025 Congress in Chicago (Nov. 30 to Dec. 4).

Oct. 30, 2025 – In collaboration with OBIO, University Health Network (UHN), Canada’s leading hospital and the No. 1 publicly funded hospital in the world, is adding a new advanced mobile X-ray machine to its radiology department. The technology, called Reveal Mobi Pro, is developed and manufactured by KA Imaging. With its increased flexibility, Reveal Mobi Pro is designed to improve the clarity and speed of imaging for patients visiting the downtown Toronto hospital – right at the bedside.

Oct. 28, 2025 — Bronchopulmonary dysplasia (BPD) is the most common — and most serious — complication of extreme prematurity. Yet clinicians still lack a reliable way to measure the severity of the disease or predict which infants will need long-term respiratory support.

Now, researchers at Children’s Hospital Los Angeles (CHLA) are investigating low-field MRI to safely capture both lung structure and function in these babies — offering a new window into how their fragile lungs develop.

Oct. 30, 2025 — Sirona Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Sirona Advanced Imaging Suite, marking a significant regulatory milestone and the company's first Class II medical device designation.

This clearance expands Sirona's diagnostic imaging capabilities to include PET-CT support with quantitative SUV analysis, image fusion, maximum intensity projection (MIP) generation and multi-planar reconstruction (MPR). 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now